Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00ESG
|
||||
Former ID |
DNC012075
|
||||
Drug Name |
4-Pyridin-2-yl-piperazine-1-carboxylic acid amide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527001] | ||
Structure |
Download2D MOL |
||||
Formula |
C10H14N4O
|
||||
Canonical SMILES |
C1CN(CCN1C2=CC=CC=N2)C(=O)N
|
||||
InChI |
1S/C10H14N4O/c11-10(15)14-7-5-13(6-8-14)9-3-1-2-4-12-9/h1-4H,5-8H2,(H2,11,15)
|
||||
InChIKey |
XYIDWLYTWKIZQC-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Vanilloid receptor | Target Info | Inhibitor | [527001] | |
Vanilloid receptor 1 | Target Info | Inhibitor | [527001] | ||
Transient receptor potential cation channel subfamily V member 4 | Target Info | Inhibitor | [527001] | ||
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | ||||
Trk receptor signaling mediated by PI3K and PLC-gamma | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.